Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-03-04 @ 8:38 PM
Study NCT ID:
NCT00181532
Status:
COMPLETED
Last Update Posted:
2009-06-30
First Post:
2005-09-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC
Sponsor:
Maastricht Radiation Oncology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
P02.1376L
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |